Article Hero

MedLife Stock (BVB: M)

9 minutes
Cristian Cochintu
Cristian Cochintu
23 November 2023

Despite a grim 2022, MedLife shares remained very popular among Romanian investors and international best-performing funds. With a +11% YTD performance in 2023 (as of 24 August), MedLife is in the top 10 best performing BVB stocks in the first 7 months of the year. While you can buy MedLife shares directly, sometimes it's worth considering an ETF with MedLife representation.

MedLife is a leading private healthcare provider in Romania. The company operates the largest network of clinics, one of the largest networks of medical laboratories, general and specialist hospitals and has the largest customer base for preventive health packages in the country. In terms of sales, the company is one of the largest private healthcare companies in Central and Eastern Europe, according to MedLife Group's public information.

The shares issued by MedLife SA are admitted to trading on the regulated spot market managed by the Bucharest Stock Exchange (BVB), Premium Category, with the trading symbol "M".

MedLife Shares - Research and Ratings

  • Are M stocks undervalued compared to their fair value, analyst forecasts, and its price relative to the market? 
  • What is the analyst’s 12-month MedLife shares price forecast? 
  • What are MedLife’s shares future growth expectations? 
  • How had M stocks performed over the past 5 years?
  • Should you buy MedLife shares or invest in ETFs with M representation?

Still not ready to invest real money? Build your confidence in a risk-free environment by testing on a demo account with $50,000 virtual funds.

MedLife Shares (BVB: M) - A brief history

MedLife is a healthcare provider company based in Romania founded in 1996. The chain of clinics owned by MedLife SA is composed of seven hyper clinics, eight own analysis laboratories and 28 general medical centers, having partnerships with more than 110 clinics throughout the country.
MedLife owns the largest private hospital in Romania, Life Memorial Hospital, the result of an investment of more than 10 million euros. The hospital provides many specialties: general and plastic surgery, ophthalmology, dermatology, ENT, pediatrics, gynecology, maternity and neonatology, oncology, etc.
In February 2011, MedLife purchased a 55% majority stake in the private medical group Genesys Medical Clinic in Arad for €2 million.

MedLife shares distribution:

Legal entities: 41,1486 %
MARCU MIHAIL: 15,0013 %
MARCU NICOLAE: 10,4127 %
Individuals: 6,1552 %

Medlife Shares (BVB: M) - Fundamental Analysis and Financial Ratings

See the latest MedLife SA stock price analysis, including valuation, future growth, past performance, and more to help you make more informed investing decisions.


Are MedLife shares undervalued compared to their fair value, analyst forecasts and its price relative to the market?

  • M shares have a good value based on their Price-To-Sales Ratio (1.3x) compared to the peer average (3.6x).
  • M shares are expensive based on their Price-To-Sales Ratio (1.3x) compared to the European Healthcare industry average (0.7x)
  • M share price (RON19.16) is trading below estimate of fair value (RON40.66)
  • M shares are being traded below fair value by more than 20%.

Future Growth

  • MedLife's revenue (10.6% per year) vs Market is forecast to grow faster than the RO market (-1.5% per year).
  • MedLife's High Growth Revenue (10.6% per year) is forecast to grow slower than 20% per year.
  • MedLife's Return on Equity is forecast to be high in 3 years’ time (22.5%).

Past Performance

Med Life has been growing earnings at an average annual rate of 35.9%, while the Healthcare industry saw earnings growing at 13.6% annually. Revenues have been growing at an average rate of 20.4% per year. Med Life's return on equity is 3.3% while the company’s net margins are 0.6%.

  • MedLife has a large one-off loss of RON8.0M impacting its last 12 months of financial results to March 31 2023.
  • MedLife's current net profit margins (0.6%) are lower than last year (6.4%).
  • MedLife's earnings have grown significantly by 35.9% per year over the past 5 years.
  • In terms of accelerating growth MedLife has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
  • M had negative earnings growth (-87.6%) over the past year, making it difficult to compare its earnings to the Healthcare industry average (-1.3%).
  • MedLife's Return on Equity (3.3%) is considered low.

Financial Health

MedLife has a total shareholder equity of RON486.9M and total debt of RON979.5M, which brings its debt-to-equity ratio to 201.2%. Its total assets and total liabilities are RON2.2B and RON1.8B respectively. Med Life's EBIT is RON89.0M, making its interest coverage ratio 1.8. The company has cash and short-term investments of RON118.3M.

  • MedLife's short term assets (RON478.2M) do not cover its short-term liabilities (RON564.7M).
  • MedLife's short term assets (RON478.2M) do not cover its long-term liabilities (RON1.2B).
  • M's net debt to equity ratio (176.9%) is considered high.
  • Medlife's debt to equity ratio has increased from 169.2% to 201.2% over the past 5 years.
  • Company's debt is well covered by operating cash flow (21.6%).
  • Medlife's interest payments on its debt are not well covered by EBIT (1.8x coverage).

MedLife Dividend

Med Life does not have a record of paying dividends.

MedLife Shares Price Forecast

According to the consensus target price for shares in Med Life SA is RON20.87.  That is 8.81% above the last closing price of RON19.18. Analysts covering Med Life SA currently have a consensus Earnings Per Share (EPS) forecast of RON0.51 for the next financial year.

As per forecasts MedLife shares are expected to be priced at 18.76 by the end of this quarter and at 17.49 in one year, according to Trading Economics global macro models projections and analysts' expectations.

There are no 5-year MedLife shares price forecasts and price predictions. 

Important: When considering MedLife's fundamental analysis, financial rating and price predictions, it’s important to remember that high market volatility and changing economic environment makes it difficult to give long-term estimates. As such, analysts and algorithm-based platforms can and do get their ratings and predictions wrong. Always do your own research before making an investment decision. And never trade or invest more than you can afford to lose. 

MedLife Shares - Technical Analysis

From a long-term perspective, MedLife shares are are being trade within a range since mid-2022 as seen on the daily M shares chart below.


However, price reached a local bottom at the end of November 2022 and seems to be forming an asymmetric inverted Head and Shoulders pattern, with the neckline in the 20.20 RON area which is the current key resistance area. A break above this level would open the door towards the 23.55 level.
In contrast, if the resistance remains in place, bulls might be tempted to close their long positions which might trigger another leg down.

How to Invest in MedLife

Some investors want to take an active hand in managing their investments, while others prefer to set it and forget it. Your preference may change but decide on an approach to get started. 

For most people, stock market investing means choosing among these two investment types: 

Individual MedLife shares  

If you’re after a specific company, you can buy a single share or a few shares to dip your toe into the stock-trading waters. Building a diversified portfolio out of many individual stocks is possible, but it takes significant investment and research. 

If you go this route, remember that individual stocks will have ups and downs. If you research a company and choose to invest in it, think about why you picked that company in the first place if jitters start to set in on a down day. 

Traditional stockbrokers allow you to invest in local stocks. However, you might not be able to invest in international stocks listed on the major stock exchanges, global ETFs, and other assets. 


ETFs with MedLife holdings 

MedLife shares (or any single stock, for that matter) can be a very volatile investment. You can manage the risk you see extreme highs and lows by diversifying your investment holdings. An ETF, for instance, contains a basket of individual stocks. When you invest in a fund, you also own small pieces of each of those companies. 

If you want an ETF with M representation, you might consider iShares MSCI Frontier and Select ETF. BlackRock's iShares is the largest provider of ETFs as calculated by assets under management. 

iShares_MSCI Frontier_and_Select_EM_ETF.png.png

The fund can be suitable for Romania and foreign investors who want liquid and diversified exposure to another top 9 companies listed on the Bucharest Stock Exchange: Banca Transilvania SA, OMV Petrom SA, Romgaz SA, BRD Groupe Société Générale, Electrica SA, Nuclearelectrica, One United Properties SA and TeraPlast SA. 


Why invest in MedLife Shares via FM? 

With net assets of almost $1B, The iShares MSCI Frontier and Select EM ETF (FM) is the largest exchange-traded-fund that seeks to track the investment results of an index composed primarily of frontier market equities along with select emerging market equities. 

  • Exposure to frontier market stocks and smaller size emerging market stocks with an emphasis on tradability and investability of the underlying constituents 
  • One-click access to a virtually untapped investment portfolio, including Bucharest Stock Exchange and BET index exposure. 
  • Use to seek long-term growth and diversification.


How to Get Started with 

Here is how to buy and trade stocks, ETFs and other assets with an international, highly regulated broker like 

  • Choose which type of account you want to use. Your first concern should be your risk appetite and time horizon. If you want to buy and hold shares, open an Invest account. If you want to speculate on price movements (including falling prices) with zero commission and leverage, open a CFD trading account. 
  • Create an account. Regardless of your chosen account, you need to register and complete the KYC process to verify your identity. 
  • Fund your account with fiat money. Before buying and trading stocks and ETFs, you need to fund your exchange account with U.S. dollars, Euros, or other currencies. 
  • Place your order. Click on the "Search" icon located in the left panel or by clicking on "ETFs" and then select the instrument, such as "iShares MSCI Frontier and Select EM ETF”. 

When trading stocks, the CFDs (contracts for difference) are stored in your account and are more liquid than the underlying asset.  

However, you should be aware that CFD trading is fast-moving and requires close monitoring. As a result, traders should be aware of the significant risks when trading CFDs. There are margins you need to maintain; if you cannot cover reductions in values, your position might be closed, and you'll have to meet the loss no matter what subsequently happens to the underlying asset. 

With CAPEX, you can trade CFDs on +2.000 stocks and invest in +5.000 stocks and ETFs with ownership. 

Free resources 

Before you start investing in shares, you should consider using the educational resources we offer like CAPEX Academy or a demo trading account. CAPEX Academy has lots of free trading courses for you to choose from, and they all tackle a different financial concept or process – like the basics of analyses – to help you to become a more informed trader. 

Our demo account is a great place for you to learn more about leveraged trading, and you’ll be able to get an intimate understanding of how CFDs work – as well as what it’s like to trade with leverage – before risking real capital. For this reason, a demo account with us is a great tool for investors who are looking to make a transition to leveraged trading. 


BVB - Actiuni M MedLife S.A.
Med Life SA Share Price - BSE:M Stock Research | Stockopedia
Med Life SA Stock Price Today | BX ROM Live Ticker -
Med Life (M) Analysts Prediction, Stock Forecast & Price Targets - Simply Wall St
Med Life | M - Stock Price | Live Quote | Historical Chart (






Cristian Cochintu
Cristian Cochintu

Cristian Cochintu writes about trading and investing for Cristian has more than 15 years of brokerage, freelance, and in-house experience writing for financial institutions and coaching financial writers.